Neofordex 40 mg (dexamethasone): removal of the score-line and the associated 20 mg posology

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Neofordex
Active substance
dexamethasone
Therapeutic area (MeSH)
Multiple Myeloma
Procedure number
EMEA/H/C/004071/II/0017-G
Regulatory outcome
Variation
DHPC type
Change in dosing recommendation
Human ATC code
H02AB02
Dissemination date
17/02/2023

How useful was this page?

Add your rating